IXHL · Incannex Healthcare Inc. · Executive Compensation

$2.10 +0.08 (+3.95%)

Market Cap

$25.34M

12.55M

Volume · Nov 12 104.35K Avg daily vol (3M) 84.42K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2026

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joel Latham	Chief Executive Officer	$790,000	$395,000	$5,200,000	—	—	$142,200	$6,527,200
Joseph Swan	Chief Financial Officer	$198,256	$39,651	$200,000	—	—	$28,549	$466,456
Luigi M. Barbato	Chief Medical Officer	$375,000	—	—	—	—	$9,728	$384,728

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joel Latham	Chief Executive Officer	$656,464	$395,000	—	—	—	$173,586	$1,125,050
Luigi M. Barbato	Chief Medical Officer	$264,063	—	$233,104	—	—	—	$497,167
Joseph Swan	Chief Financial Officer	$150,650	$39,651	—	—	—	$20,413	$210,714

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Joel Latham	Chief Executive Officer	$595,958	—	$5,494,000	—	—	$126,124	$6,216,082
Joseph Swan	Chief Financial Officer	$107,940	$26,873	$117,332	—	—	$11,862	$264,007
Luigi M. Barbato	Chief Medical Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Luigi M. Barbato, M.D.	Chief Medical Officer	Appointed	2024-10-21	2024-10-24
Joseph Swan	Chief Financial Officer and Secretary	Appointed	2024-02-29	2024-03-05
Madhukar Bhalla	Chief Financial Officer and Secretary	Resigned	2024-02-28	2024-03-05

Leadership

Joel Latham CEO, Board Member
Joseph Swan CFO
Lekhram Changoer CTO
Dr. George Anastassov Board Member
Peter Widdows Board Member
Robert Clark Board Member

Key facts CIK 1873875 CUSIP 45333F208 13F (30d) 12 filings 12 filers Visit website Investor relations